These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 31078050)

  • 1. Nanomaterial designing strategies related to cell lysosome and their biomedical applications: A review.
    Rathore B; Sunwoo K; Jangili P; Kim J; Kim JH; Huang M; Xiong J; Sharma A; Yang Z; Qu J; Kim JS
    Biomaterials; 2019 Aug; 211():25-47. PubMed ID: 31078050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-Death or Pro-Survival: Contrasting Paradigms on Nanomaterial-Induced Autophagy and Exploitations for Cancer Therapy.
    Zhang Y; Zhang L; Gao J; Wen L
    Acc Chem Res; 2019 Nov; 52(11):3164-3176. PubMed ID: 31621285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity.
    Stern ST; Adiseshaiah PP; Crist RM
    Part Fibre Toxicol; 2012 Jun; 9():20. PubMed ID: 22697169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Search of a Converging Cellular Mechanism in Nanotoxicology and Nanomedicine in the Treatment of Cancer.
    Gulumian M; Andraos C
    Toxicol Pathol; 2018 Jan; 46(1):4-13. PubMed ID: 29034767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions.
    Sharma A; Vaghasiya K; Ray E; Verma RK
    J Drug Target; 2018 Mar; 26(3):208-221. PubMed ID: 28862054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
    Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
    Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting endocytosis for nanomedicines.
    Akinc A; Battaglia G
    Cold Spring Harb Perspect Biol; 2013 Nov; 5(11):a016980. PubMed ID: 24186069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future of nanotherapeutics: Targeting the cellular sub-organelles.
    Ma X; Gong N; Zhong L; Sun J; Liang XJ
    Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment.
    Ma X; Wu Y; Jin S; Tian Y; Zhang X; Zhao Y; Yu L; Liang XJ
    ACS Nano; 2011 Nov; 5(11):8629-39. PubMed ID: 21974862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Nanomaterials and Related Drug Delivery Systems in Autophagy.
    Mei L; Liao K; Chen H; Zhang Y; Zhang Z; Li Q; Li M
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular.
    Buratta S; Tancini B; Sagini K; Delo F; Chiaradia E; Urbanelli L; Emiliani C
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graphene oxide induces p62/SQSTM-dependent apoptosis through the impairment of autophagic flux and lysosomal dysfunction in PC12 cells.
    Feng X; Chen L; Guo W; Zhang Y; Lai X; Shao L; Li Y
    Acta Biomater; 2018 Nov; 81():278-292. PubMed ID: 30273743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant Cellular Vacuoles Induced by Rare Earth Oxide Nanoparticles are Abnormally Enlarged Endo/Lysosomes and Promote mTOR-Dependent TFEB Nucleus Translocation.
    Lin J; Shi SS; Zhang JQ; Zhang YJ; Zhang L; Liu Y; Jin PP; Wei PF; Shi RH; Zhou W; Wen LP
    Small; 2016 Nov; 12(41):5759-5768. PubMed ID: 27593892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tunable resistive pulse sensing: potential applications in nanomedicine.
    Sivakumaran M; Platt M
    Nanomedicine (Lond); 2016 Aug; 11(16):2197-214. PubMed ID: 27480794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytic mechanisms for targeted drug delivery.
    Bareford LM; Swaan PW
    Adv Drug Deliv Rev; 2007 Aug; 59(8):748-58. PubMed ID: 17659804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology for neurodegenerative disorders.
    Re F; Gregori M; Masserini M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S51-8. PubMed ID: 22640910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LYST affects lysosome size and quantity, but not trafficking or degradation through autophagy or endocytosis.
    Holland P; Torgersen ML; Sandvig K; Simonsen A
    Traffic; 2014 Dec; 15(12):1390-405. PubMed ID: 25216107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E; Dini L
    Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomedical Applications of Nanomaterials as Therapeutics.
    Ng CT; Baeg GH; Yu LE; Ong CN; Bay BH
    Curr Med Chem; 2018; 25(12):1409-1419. PubMed ID: 28393698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.